Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary hemochromatosis

E M Walker1, M D Wolfe, M L Norton

  • 1Department of Pathology, Huntington DVA Medical Center, WV, USA.

Annals of Clinical and Laboratory Science
|October 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semipermeable species boundaries create opportunities for gene flow and adaptive potential.

Molecular ecology·2023
Same author

[Morphological changes in rabbit cornea after implantation of a new keratoprosthesis supporting plate].

Vestnik oftalmologii·2020
Same author

The C-terminal region of the major outer sheath protein of Treponema denticola inhibits neutrophil chemotaxis.

Molecular oral microbiology·2017
Same author

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

Leukemia·2017
Same author

Impact of Pdx1-associated chromatin modifiers on islet β-cells.

Diabetes, obesity & metabolism·2016
Same author

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

Leukemia·2016
Same journal

<i>Letter to the Editor:</i> Detection of <i>Chlamydia trachomatis</i> Immunoglobulin E Antibody in Human Sera.

Annals of clinical and laboratory science·2026
Same journal

Comparison of the DNA Preservation Capacity of Two Methods for the Long-Term Cryopreservation of Whole Blood Samples.

Annals of clinical and laboratory science·2026
Same journal

Recurrence of Primary Mediastinal Yolk Sac Tumor with Brain Metastases: A Case Report and Literature Review.

Annals of clinical and laboratory science·2026
Same journal

Intraoperative Imprint Cytology of <i>SMARCB1</i>-Mutant Desmoplastic Myxoid Tumor of the Pineal Region: A Case Report with Cytologic Differential Diagnosis and Literature Review.

Annals of clinical and laboratory science·2026
Same journal

Bergenin Suppresses Glycolysis and Malignant Progression in Breast Cancer via the IGF1R-MAPK Signaling Pathway.

Annals of clinical and laboratory science·2026
Same journal

Network Pharmacology and <i>in vitro</i> Experimental Validation Reveal the Anticancer Mechanisms of Cichoric Acid in Cervical Cancer.

Annals of clinical and laboratory science·2026
See all related articles

Genetic hemochromatosis is a common disorder causing iron overload. Early screening and treatment, including phlebotomy, can prevent severe organ damage and premature death.

Area of Science:

  • Genetics
  • Gastroenterology
  • Internal Medicine

Background:

  • Hereditary hemochromatosis is a prevalent autosomal recessive disorder in white Americans.
  • It involves excessive iron absorption and storage in organs, potentially leading to severe dysfunction and death.
  • The hemochromatosis gene is linked to the HLA-A locus on chromosome 6.

Purpose of the Study:

  • To highlight the importance of early diagnosis and treatment for hereditary hemochromatosis.
  • To outline screening methods and at-risk populations.
  • To emphasize the preventative benefits of early intervention.

Main Methods:

  • Population screening with serum iron, TIBC, transferrin saturation, and ferritin.
  • Genetic testing for individuals at risk.

Related Experiment Videos

  • Liver biopsies for differential diagnosis.
  • Treatment with phlebotomy and iron-chelating agents.

    • Main Results:

    • Early diagnosis and treatment can prevent iron-induced organ damage (pituitary, pancreatic, cardiac, liver).
    • Screening identifies individuals at risk, including family members.
    • Effective management can avert serious complications like cardiac arrhythmias, heart failure, liver failure, and cancer.

    Conclusions:

    • Early screening and treatment of hereditary hemochromatosis are crucial for preventing severe complications and premature mortality.
    • Proactive management can significantly reduce healthcare costs associated with this disease.
    • Screening should commence by age 20 for at-risk individuals.